© 2018, Xoft, a subsidiary of iCAD Inc.  All rights reserved.  Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are registered trademarks of iCAD, Inc..

 Xoft offers patients and physicians a non-invasive alternative to surgery for non-melanoma skin cancer (NMSC) treatment. With the Xoft System, painless, scar-free treatment of NMSC is possible with skin eBx, a form of high dose rate, low energy radiation therapy.

By delivering a precise dose of targeted radiation directly to the area, skin eBx offers suitable patients a non-surgical solution while limiting exposure to surrounding healthy tissue. Skin eBx provides a convenient option allowing patients to return to normal activities almost immediately with virtually no downtime.

 

1. Originally published in The Journal of Contemporary Brachytherapy 2017; 9, 3: 1-7

Squamous cell carcinoma 
Treated with 40 Gy to a 3 mm depth

Pre-Treatment

One Year 

Skin eBx Clinical Data Selected at
Best of ASTRO Meeting 2017

"Most Relevant and Highly Influential Abstract"

 

• R. Patel, et al. "Comparison of Electronic Brachytherapy and Mohs Micrographic Surgery – A Matched Pair Cohort Study for Treatment of Non-Melanoma Skin Cancer."

• Results show comparable recurrence rates and cosmetic outcomes for treatment of appropriately-selected NMSC using Xoft System compared to Mohs surgery
1

• 416 lesions
• Excellent cosmesis
• 3.4 years mean follow-up
• <1% recurrence rate

Pre-book your presentation or demonstration today.

Join us in Xoft booth #1121 to explore the unique and valuable benefits this innovative technology can offer to you, your practice and your patients.